Ronan O'Brien

General Counsel, Pear Therapeutics (United States).

Companies

Pear Therapeutics (United States)CCO, GC, & Secretary Feb 18, 2022 to Feb 17, 2023¹
Pear Therapeutics (United States)General counsel Dec 7, 2021 to Dec 7, 2021²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Pear Therapeutics (United States)18,638 shares³Jan 20, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Jan 20, 2023Sold 12,162 shares at $1.13 of Pear Therapeutics (United States)³
Jan 14, 2023Exercised options 30,800 shares of Pear Therapeutics (United States)⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARPear Therapeutics (United States), CCO, GC, & Secretary
2
SEC EDGARPear Therapeutics (United States), General counsel
3
SEC EDGARPear Therapeutics (United States) shares after the filing of Jan 20, 2023
4
SEC EDGARForm 4 filed Jan 18, 2023